Two Japanese Firms Set to Acquire Eu Yan Sang
SINGAPORE: In a strategic move to expand their presence in Southeast Asia, Japan’s Rohto Pharmaceutical and Mitsui & Co have announced plans to acquire prominent Traditional Chinese Medicine (TCM) chain Eu Yan Sang for $800 million. The acquisition, facilitated by a joint venture between the two companies, involves establishing a local special-purpose company to purchase … Read more